Podcasts

For decades, Chinese Hamster Ovary (CHO) cells have been the gold standard for manufacturing biologic drugs, including monoclonal antibodies and many advanced therapeutics. But a new technology is gaining momentum: plant-made biologics.

In this video, I compare traditional CHO cell manufacturing with plant-based production systems and explain why many researchers believe plants could transform the future of biologics.

We'll discuss:
🌿 How plants can produce complex therapeutic proteins
🧬 Why CHO cells became the industry standard
💰 Manufacturing costs and scalability
⚡ Speed of production during pandemics and disease outbreaks
🦠 Safety differences, including contamination risks
🔬 Glycosylation and why it matters
🐶 What this technology could mean for veterinary medicine
🚀 The future of plant-made biologics and regenerative medicine

As a veterinarian, I'm fascinated by how advances in biotechnology may change the way we develop therapies—not only for people but also for our pets.

If you enjoy evidence-based discussions about veterinary medicine, biotechnology, and the future of animal health, subscribe for more deep dives.

What do you think? Could plants eventually replace CHO cells for manufacturing biologics?

#Biologics #Biotechnology #CHOCells #PlantMadeBiologics #VeterinaryMedicine #MonoclonalAntibodies #Biopharmaceuticals #Science #Phylloceuticals #FutureOfMedicine #Biotech #DrugDevelopment